Development and acceptability testing of a decision aid for considering whether to reduce antipsychotics in individuals with stable schizophrenia

AIM: Continued antipsychotic treatment is the key to preventing relapse. Maintenance antipsychotic monotherapy and optimal dose use are recommended for individuals with stable schizophrenia because of their undesirable effects. Decision aids (DAs) are clinical conversation tools that facilitate shar...

Descripción completa

Detalles Bibliográficos
Autores principales: Aoki, Yumi, Takaesu, Yoshikazu, Matsui, Kentaro, Tokumasu, Takahiro, Tani, Hideaki, Takekita, Yoshiteru, Kanazawa, Tetsufumi, Kishimoto, Taishiro, Tarutani, Seiichiro, Hashimoto, Naoki, Takeuchi, Hiroyoshi, Mishima, Kazuo, Inada, Ken
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10496039/
https://www.ncbi.nlm.nih.gov/pubmed/37452456
http://dx.doi.org/10.1002/npr2.12366

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10496039/
https://www.ncbi.nlm.nih.gov/pubmed/37452456
http://dx.doi.org/10.1002/npr2.12366

Ejemplares similares